Get the Stockscreener App
9.31
0.43%
0.04
Corbus Pharmaceuticals Holdings Inc stock is traded at $9.31, with a volume of 122.15K.
It is up +0.43% in the last 24 hours and up +30.03% over the past month.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
See More
Previous Close:
$9.27
Open:
$9.1
24h Volume:
122.15K
Relative Volume:
0.80
Market Cap:
$113.92M
Revenue:
$1.54M
Net Income/Loss:
$-38.70M
P/E Ratio:
-1.9936
EPS:
-4.67
Net Cash Flow:
$-36.86M
1W Performance:
+0.54%
1M Performance:
+30.03%
6M Performance:
-4.90%
1Y Performance:
-84.24%
1-Day Range:
$9.095
$9.67
1-Week Range:
$9.00
$10.05
52-Week Range:
$4.64
$61.89
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
Name
Corbus Pharmaceuticals Holdings Inc
Sector
Industry
Phone
617-963-0103
Address
500 RIVER RIDGE DRIVE, NORWOOD, MA
Compare CRBP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRBP
Corbus Pharmaceuticals Holdings Inc
|
9.31 | 113.43M | 1.54M | -38.70M | -36.86M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-30-25 | Resumed | B. Riley Securities | Buy |
| Feb-28-25 | Initiated | William Blair | Outperform |
| Dec-02-24 | Initiated | Piper Sandler | Overweight |
| Jul-30-24 | Initiated | Wedbush | Outperform |
| Jul-22-24 | Resumed | H.C. Wainwright | Buy |
| Jun-26-24 | Initiated | B. Riley Securities | Buy |
| Jun-03-24 | Reiterated | Oppenheimer | Outperform |
| May-13-24 | Initiated | RBC Capital Mkts | Outperform |
| Mar-06-24 | Upgrade | Jefferies | Hold → Buy |
| Sep-08-20 | Downgrade | BTIG Research | Buy → Neutral |
| Sep-08-20 | Downgrade | Jefferies | Buy → Hold |
| Sep-08-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-08-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Jul-07-20 | Initiated | ROTH Capital | Buy |
| Jun-17-20 | Initiated | BTIG Research | Buy |
| Mar-26-20 | Initiated | Nomura | Buy |
| Apr-05-19 | Initiated | Jefferies | Buy |
| Mar-20-19 | Initiated | Oppenheimer | Outperform |
| Jan-11-19 | Reiterated | Cantor Fitzgerald | Overweight |
| Dec-26-18 | Initiated | H.C. Wainwright | Buy |
| Dec-07-18 | Initiated | RBC Capital Mkts | Outperform |
| Oct-24-18 | Initiated | B. Riley FBR | Buy |
| Jan-19-18 | Initiated | Raymond James | Outperform |
| Dec-14-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Nov-08-17 | Reiterated | Noble Financial | Buy |
| Sep-29-17 | Resumed | Noble Financial | Buy |
| Mar-30-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Nov-15-16 | Reiterated | JMP Securities | Mkt Outperform |
| Nov-11-16 | Reiterated | Noble Financial | Buy |
View All
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Latest News
What are Corbus Pharmaceuticals Holdings Inc. company’s key revenue driversFree Stock Review Backed By Experts - jammulinksnews.com
Why is Corbus Pharmaceuticals Holdings Inc. stock attracting strong analyst attentionReal Time Tracker For Fast Growth - jammulinksnews.com
Dermatomyositis Treatment Market 2034: EMA, PDMA, FDA - openPR.com
Corbus Pharmaceuticals Announces Upcoming Presentation of - GlobeNewswire
Corbus to present updated CRB-701 cancer drug data at ESMO 2025 - Investing.com UK
Corbus Pharmaceuticals stock rises after ESMO abstract acceptance By Investing.com - Investing.com Nigeria
Corbus Pharmaceuticals stock rises after ESMO abstract acceptance - Investing.com Australia
CRBP: B. Riley Maintains Buy Rating with Promising Drug Potential - GuruFocus
Corbus Pharmaceuticals (CRBP) to Present Phase 1/2 Study Data at ESMO 2025 - GuruFocus
Corbus Pharmaceuticals Announces Upcoming Presentation of Dose E - GuruFocus
Corbus Pharmaceuticals Announces Upcoming Presentation of Dose Expansion Phase 1/2 Clinical Data for its Nectin-4 Targeting ADC CRB-701 at the 2025 ESMO Annual Congress | CRBP Stock News - GuruFocus
Corbus Pharmaceuticals Announces Upcoming Presentation of Dose Expansion Phase 1/2 Clinical Data for its Nectin-4 Targeting ADC CRB-701 at the 2025 ESMO Annual Congress - GlobeNewswire
Latest Clinical Data: Corbus' Next-Gen Cancer Drug Targets Multiple Advanced TumorsESMO 2025 Preview - Stock Titan
Strategies to average down on Corbus Pharmaceuticals Holdings Inc.Real Time Growth Signal with Smart Setup - Newser
How to build a custom watchlist for Corbus Pharmaceuticals Holdings Inc.Buy Opportunity Forecast for Fast Traders - Newser
Has Corbus Pharmaceuticals Holdings Inc. Stock Ever Crashed Historical Volatility ReviewDaily Stock Market Swing Alerts Highlight Key Movers - metal.it
How Corbus Pharmaceuticals Holdings Inc. stock performs during market volatilityFree Wealth Building Stock Market Ideas - Newser
Corbus Pharmaceuticals Holdings Inc. Stocks Attracting Dip BuyersLow Capital High Return Stock Plans Reviewed - metal.it
Published on: 2025-07-30 03:29:01 - metal.it
Published on: 2025-07-29 15:46:28 - metal.it
What MACD signals say about Corbus Pharmaceuticals Holdings Inc.Free Real Time Alerts Based on AI Prediction - Newser
Applying chart zones and confluence areas to Corbus Pharmaceuticals Holdings Inc.High Reward Investment Strategy for Beginners - Newser
Published on: 2025-07-29 13:25:17 - metal.it
How moving averages guide Corbus Pharmaceuticals Holdings Inc. tradingSummary of Trade Cycles in 5-Year Range - Newser
Will earnings trigger a reversal in Corbus Pharmaceuticals Holdings Inc.Free Trend Following Strategy With Stop Loss - Newser
Published on: 2025-07-29 12:01:12 - metal.it
How Interest Rate Changes Impact Corbus Pharmaceuticals Holdings Inc. Stock PerformanceFree Proven Entry Plan With Low Risk Trade - Newser
Published on: 2025-07-29 15:57:58 - Newser
Is Corbus Pharmaceuticals Holdings Inc. a growth stock or a value stockFree Wealth Planning Blueprint - jammulinksnews.com
How many analysts rate Corbus Pharmaceuticals Holdings Inc. as a “Buy”Capitalize on momentum stocks early - jammulinksnews.com
When is Corbus Pharmaceuticals Holdings Inc. stock expected to show significant growthUnlock exclusive trading strategies for gains - jammulinksnews.com
What machine learning models say about Corbus Pharmaceuticals Holdings Inc.Long Hold Investment Strategy with Growth Focus - Newser
How moving averages guide Corbus Pharmaceuticals Holdings Inc. trading Low Risk Strategy with Smart Entry Zones - Newser
Is it the right time to buy Corbus Pharmaceuticals Holdings Inc. stockFree Market Volatility Navigation Tips - jammulinksnews.com
What are the latest earnings results for Corbus Pharmaceuticals Holdings Inc.Free Predictions - jammulinksnews.com
Will Corbus Pharmaceuticals Holdings Inc. Stock Benefit from AI and Green Energy TrendsDaily Volume Leaders - Newser
What analysts say about Corbus Pharmaceuticals Holdings Inc. stockExceptional profit potential - Autocar Professional
When is the best time to buy Corbus Pharmaceuticals Holdings Inc. stockUnprecedented profits - jammulinksnews.com
Corbus Pharmaceuticals Holdings Inc. Stock Analysis and ForecastFree Predictions - PrintWeekIndia
What drives Corbus Pharmaceuticals Holdings Inc. stock priceHigh-return market picks - PrintWeekIndia
Is Corbus Pharmaceuticals Holdings Inc. a good long term investmentOutstanding stock performance - Autocar Professional
Why Corbus Pharmaceuticals Holdings Inc. stock attracts strong analyst attentionElite Stock Shortlist - Newser
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Altmeyer Anne | Director |
May 30 '25 |
Sale |
7.25 |
1,392 |
10,096 |
1,391 |
| Smethurst Dominic | Chief Medical Officer |
Mar 06 '25 |
Sale |
6.78 |
6,393 |
43,330 |
70,807 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):